These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
544 related items for PubMed ID: 20508897
1. Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none. Tangelder MJ, van Hattum ES. Thromb Haemost; 2010 Aug; 104(2):196-9. PubMed ID: 20508897 [No Abstract] [Full Text] [Related]
2. Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation. Spyropoulos AC, Douketis JD. Int Angiol; 2008 Aug; 27(4):333-43. PubMed ID: 18677297 [No Abstract] [Full Text] [Related]
4. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative]. Själander A, Wallentin L, Rosenqvist M, Svensson P. Lakartidningen; 2016 Apr; 105(37):2478-80. PubMed ID: 19006862 [No Abstract] [Full Text] [Related]
5. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer]. Mooe T. Lakartidningen; 2016 Apr; 105(37):2472-3. PubMed ID: 19006861 [No Abstract] [Full Text] [Related]
6. Antithrombotic therapy in peripheral arterial disease. Lipsitz EC, Kim S. Clin Geriatr Med; 2006 Feb; 22(1):183-98, x. PubMed ID: 16377474 [Abstract] [Full Text] [Related]
9. Clinical pharmacology of antithrombotic drugs in coronary artery disease. Fauler J. Ther Adv Cardiovasc Dis; 2009 Dec; 3(6):465-78. PubMed ID: 19726525 [Abstract] [Full Text] [Related]
10. Is aspirin still the drug of choice for management of patients with peripheral arterial disease? Poredos P, Jezovnik MK. Vasa; 2013 Mar; 42(2):88-95. PubMed ID: 23485835 [Abstract] [Full Text] [Related]
11. Dual antiplatelet therapy in the secondary prevention of atherothrombosis: need for new therapeutic approaches. Sabatier B, Trinquart L, Emmerich J. Arch Cardiovasc Dis; 2010 Oct; 103(10):497-501. PubMed ID: 21130962 [No Abstract] [Full Text] [Related]
12. Antithrombotic strategies in patients on oral anticoagulant therapy undergoing percutaneous coronary intervention: a proposed algorithm based on individual risk stratification. Patti G, Di Sciascio G. Catheter Cardiovasc Interv; 2010 Jan 01; 75(1):128-34. PubMed ID: 19670304 [Abstract] [Full Text] [Related]
13. Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease. Poredos P, Jezovnik MK. Int Angiol; 2010 Feb 01; 29(1):20-6. PubMed ID: 20224527 [Abstract] [Full Text] [Related]
14. Antithrombotic treatment in peripheral artery disease. Olinic DM, Tataru DA, Homorodean C, Spinu M, Olinic M. Vasa; 2018 Feb 01; 47(2):99-108. PubMed ID: 29160765 [Abstract] [Full Text] [Related]
15. Antithrombotic agents and invasive procedures--hematologist point of view. Lecompte TP. Thromb Res; 2012 Oct 01; 130 Suppl 1():S61-2. PubMed ID: 23026666 [Abstract] [Full Text] [Related]
16. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. Warfarin Antiplatelet Vascular Evaluation Trial InvestigatorsMcMaster University, Hamilton, ON, Canada. anands@mcmaster.ca, Anand S, Yusuf S, Xie C, Pogue J, Eikelboom J, Budaj A, Sussex B, Liu L, Guzman R, Cina C, Crowell R, Keltai M, Gosselin G. N Engl J Med; 2007 Jul 19; 357(3):217-27. PubMed ID: 17634457 [Abstract] [Full Text] [Related]
17. Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices. Faxon DP. Rev Cardiovasc Med; 2005 Jul 19; 6 Suppl 4():S3-14. PubMed ID: 17710074 [Abstract] [Full Text] [Related]